These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 12138066

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
    Hoepffner W, Kaufhold A, Willgerodt H, Keller E.
    Horm Res; 2008; 70(1):42-50. PubMed ID: 18493149
    [Abstract] [Full Text] [Related]

  • 7. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
    Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
    Endocr Pract; 2017 May; 23(5):546-556. PubMed ID: 28225306
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
    J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
    [Abstract] [Full Text] [Related]

  • 10. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Trinh L, Nimkarn S, New MI, Lin-Su K.
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):883-91. PubMed ID: 17937061
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report.
    Roche EF, Charmandari E, Dattani MT, Hindmarsh PC.
    Clin Endocrinol (Oxf); 2003 May; 58(5):589-96. PubMed ID: 12699440
    [Abstract] [Full Text] [Related]

  • 17. Long-term Growth in Congenital Adrenal Hyperplasia.
    Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A.
    Indian J Pediatr; 2019 Feb; 86(2):154-158. PubMed ID: 30097840
    [Abstract] [Full Text] [Related]

  • 18. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
    Horm Res; 1997 Feb; 47(1):17-22. PubMed ID: 9010713
    [Abstract] [Full Text] [Related]

  • 19. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
    Sellick J, Aldridge S, Thomas M, Cheetham T.
    J Pediatr Endocrinol Metab; 2018 Sep 25; 31(9):1019-1022. PubMed ID: 30173205
    [Abstract] [Full Text] [Related]

  • 20. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form].
    Lemos-Marini SH, Guerra-Júnior G, Morcillo AM, Baptista MT, Silva LO, Maciel-Guerra AT.
    Arq Bras Endocrinol Metabol; 2005 Dec 25; 49(6):902-7. PubMed ID: 16544012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.